Get started
Work

Abstract 2580: Infiltration and spatial distribution of immune cells are associated clinical benefit from Nivolumab and Ipilimumab for previously treated patients with stage IV squamous cell lung cancer: an immune biomarker analysis of Phase III SWOG LungMAP S1400I trial

Year: 2022
Type: conference-abstract
DOI: 10.1158/1538-7445.am2022-2580
Authors: Edwin Roger Parra, Jiexin Zhang, Mary Redman, Rossana Lazcano, Piubelli Mario, Caddie Laberiano Fernandez, Renganayaki K. Krishna, Shanyu Zhang, Hong Chen, Ganiraju Manyam, Radim Moravec, Ethan Cerami, James Lindsay, Joyce Yu, Roshni Biswas, Stephen Van Nostrand, Dzifa Y. Duose, Jianjun Zhang, Roy Herbst, Gheath Al-Atrash, Kasthuri Kannan, Ignacio I. Wistuba, Scott Gettinger, Lyudmila Bazhenova, Jack Lee, Jianhua Zhang, Cara Haymaker
Institutions: The University of Texas MD Anderson Cancer Center, Fred Hutch Cancer Center, National Cancer Institute, Dana-Farber Cancer Institute, Yale University, University of California San Diego, Moores Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4282938684
Cites:
Cited by:
Related to: 10